ACLX (STOCKS)
Arcellx, Inc. Common Stock
$114.870000
+0.040000 (+0.03%)
Prev close: $114.830000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Rami Elghandour
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,716.41M
- Employees
- 163
- P/E (TTM)
- -28.32
- P/B (TTM)
- 16.53
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
20
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.01 | $-1.06 | +0.0480 | +4.54% |
|
Sep 2025 (Q3)
|
$-0.99 | $-1.08 | +0.0912 | +8.44% |
|
Jun 2025 (Q2)
|
$-0.94 | $-1.04 | +0.0978 | +9.42% |
|
Mar 2025 (Q1)
|
$-1.13 | $-0.77 | -0.3574 | -46.26% |
Financial Statements
| Revenues | $22.29M |
| Benefits Costs and Expenses | $251.15M |
| Costs And Expenses | $251.15M |
| Operating Expenses | $275.37M |
| Depreciation and Amortization | $6.70M |
| Research and Development | $157.61M |
| Other Operating Expenses | $111.06M |
| Operating Income/Loss | -$253.08M |
| Income/Loss From Continuing Operations After Tax | -$228.93M |
| Income/Loss From Continuing Operations Before Tax | -$228.87M |
| Income Tax Expense/Benefit | $69.00K |
| Net Income/Loss | -$228.93M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$228.93M |
| Net Income/Loss Available To Common Stockholders, Basic | -$228.93M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.07 |
| Diluted Earnings Per Share | -$4.07 |
| Basic Average Shares | 56,305,535 |
| Diluted Average Shares | 56,305,535 |
| Assets | $603.99M |
| Current Assets | $462.18M |
| Noncurrent Assets | $141.81M |
| Fixed Assets | $42.64M |
| Other Non-current Assets | $99.17M |
| Liabilities | $201.64M |
| Current Liabilities | $104.20M |
| Accounts Payable | $5.58M |
| Other Current Liabilities | $98.63M |
| Noncurrent Liabilities | $97.44M |
| Equity | $402.35M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $402.35M |
| Liabilities And Equity | $603.99M |
| Net Cash Flow From Operating Activities | -$210.26M |
| Net Cash Flow From Operating Activities, Continuing | -$210.26M |
| Net Cash Flow From Investing Activities | $86.30M |
| Net Cash Flow From Investing Activities, Continuing | $86.30M |
| Net Cash Flow From Financing Activities | $98.53M |
| Net Cash Flow From Financing Activities, Continuing | $98.53M |
| Net Cash Flow | -$25.43M |
| Net Cash Flow, Continuing | -$25.43M |
| Comprehensive Income/Loss | -$228.94M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$228.94M |
| Other Comprehensive Income/Loss | -$228.94M |